Literature DB >> 27719875

The role of placebo in the diagnosis and treatment of functional neurologic disorders.

K S Rommelfanger1.   

Abstract

Placebo therapy can produce meaningful, clinical relief for a variety of conditions. While placebos are not without their ethically fraught history, they continue to be used, largely covertly, even today. Because the prognosis for psychogenic disorders is often poor and recovery may be highly dependent on the patient's belief in the diagnosis and treatment regimen, some physicians find placebo therapy for psychogenic disorders compelling, but also particularly contentious. Yet placebos also have a long tradition of being used for provocative diagnosis (wherein placebo is used to elicit and/or terminate the symptoms as a way of diagnosing symptoms as "psychogenic"). In this chapter we discuss cases describing placebo as therapy for psychogenic disorders and the challenges related to embedded Cartesian beliefs in Western medicine. The legitimate ethical reservations against placebo therapy, in general, have been related to assumptions about their "inertness" and a requirement for deception, both which are being refuted by emerging data. In this chapter, we also re-evaluate the concerns associated with placebo therapy for psychogenic disorders by asking, "Are we harming patients by withholding placebo treatment?"
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  American Medical Assocation policy; complementary medicine; conversion disorder; ethics; medically unexplained illness; mind–body; movement disorders; placebo treatment; provocative testing; psychogenic; psychogenic nonepileptic seizures

Mesh:

Substances:

Year:  2016        PMID: 27719875     DOI: 10.1016/B978-0-12-801772-2.00049-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

Review 1.  Functional neurological disorder and placebo and nocebo effects: shared mechanisms.

Authors:  Mark J Edwards; Michele Tinazzi; Mirta Fiorio; Miriam Braga; Angela Marotta; Bernardo Villa-Sánchez; Diletta Barbiani
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

2.  Functional Dyskinesias following Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Report of Three Cases.

Authors:  Ricardo Maciel; Carlos Zúñiga-Ramírez; Renato P Munhoz; Mateusz Zurowski; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2020-12-02

Review 3.  Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports.

Authors:  Benjamin Stewart; Jon G Dean; Adriana Koek; Jason Chua; Rafael Wabl; Kayla Martin; Naveed Davoodian; Christopher Becker; Mai Himedan; Amanda Kim; Roger Albin; Kelvin L Chou; Vikas Kotagal
Journal:  Pharmacol Res Perspect       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.